Insight

George Vlachogiannis: The Essential Nature of Social Work in Cancer Control

George Vlachogiannis/LinkedIn

Jun 25, 2025, 02:04

George Vlachogiannis: The Essential Nature of Social Work in Cancer Control

George Vlachogiannis, Managing Editor – Cancer Control at Sage, shared a post by Anao Zhang, Associate Professor at University of Michigan School of Social Work, adding:

“The Essential Nature of Social Work in Cancer Control

In their recent Review article published in Cancer Control, Prof Brad Zebrack and colleagues from the University of Michigan highlight the critical role of social workers across the cancer care continuum – from prevention and screening, to survivorship and end-of-life care.

Social workers are uniquely trained to address the social determinants of health that drive disparities in cancer outcomes. This mini-review argues for their essential integration into oncology teams to enhance care quality, promote equity, and improve patient outcomes, particularly for marginalized populations.

As healthcare moves toward whole-person, community-aligned models, social work stands at the forefront of equitable cancer control. This is a timely call to recognize, support, and fund oncology social work as an indispensable force in advancing cancer care.”

Quoting Anao Zhang‘s post:

“Read my latest publication with Brad Zebrack, Lauren G., Nina J. Francis-Levin and Rachel Brandon in Cancer Control outlining the essential nature of social work across the cancer control spectrum.”

Title: The Essential Nature of Social Work in Cancer Control

Authors: Brad Zebrack, Anao Zhang, Lauren V. Ghazal, Nina Francis-Levin, Rachel E. Brandon

Read the Full Article.

George Vlachogiannis

More posts featuring George Vlachogiannis.

Anao Zhang Brad Zebrack cancer cancer care Lauren G. Lauren V. Ghazal Nina Francis-Levin Nina J. Francis-Levin OncoDaily Oncology Rachel Brandon Rachel E. Brandon

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Kevin Conroy: Oncodetect is Now Covered by Medicare in Stage IV Colorectal Cancer